We then analyzed the association of expression groups (CD133-/BMI-1-, CD133+/BMI-1-, CD133-/BMI-1+ and CD133+/BMI-1+) with survival of pancreatic cancer patients. The gene discussed is BMI1; the disease is familial pancreatic carcinoma.